Insmed Incorporated To Participate In Leerink Partners’ Rare Disease Roundtable

Insmed Incorporated (Nasdaq:INSM), announces that Company management will participate in the upcoming Leerink Partners’ Rare Disease Roundtable taking place October 1, 2014 at Le Parker Meridian Hotel in New York City. Will Lewis, Insmed’s President and Chief Executive Officer, will participate in a fireside chat with Leerink Partners’ analyst, Joseph P. Schwartz, at 2:20 p.m. Eastern time.

Help employers find you! Check out all the jobs and post your resume.